|
KR100217772B1
(ko)
*
|
1996-09-03 |
1999-09-01 |
최진호 |
조명기기의 램프 과열방지 장치 및 방법
|
|
US20020092987A1
(en)
*
|
1998-09-05 |
2002-07-18 |
Taehee Cho |
Photo detect device using quantum dots and materialization method thereof
|
|
US6936258B1
(en)
*
|
1999-03-19 |
2005-08-30 |
Nabi Biopharmaceuticals |
Staphylococcus antigen and vaccine
|
|
PT1565478T
(pt)
|
2002-11-12 |
2017-11-14 |
The Brigham And Women`S Hospital Inc |
Vacina de polissacáridos para infeções estafilocócicas
|
|
WO2004050846A2
(en)
*
|
2002-12-02 |
2004-06-17 |
Biosynexus Incorporated |
Wall teichoic acid as a target for anti-staphylococcal therapies and vaccines
|
|
JP5102487B2
(ja)
*
|
2003-03-07 |
2012-12-19 |
ワイス・ホールディングズ・コーポレイション |
院内感染に対する免疫化のための多糖ブドウ球菌表面付着因子キャリアタンパク質接合体
|
|
AU2011265368B9
(en)
*
|
2004-09-22 |
2012-11-29 |
Biosynexus Incorporated |
Immunogenic composition
|
|
RU2402347C2
(ru)
*
|
2004-09-22 |
2010-10-27 |
ГлаксоСмитКлайн Байолоджикалз с.а. |
Иммуногенная композиция
|
|
US20060134141A1
(en)
*
|
2004-12-14 |
2006-06-22 |
Nabi Biopharmaceuticals |
Glycoconjugate vaccines containing peptidoglycan
|
|
AU2005324448A1
(en)
*
|
2005-01-10 |
2006-07-20 |
Glaxosmithkline Biologicals Sa |
Method of treating Staphylococcus aureus infection
|
|
US20060228368A1
(en)
*
|
2005-04-07 |
2006-10-12 |
Nabi Biopharmaceuticals |
Method of protecting against staphylococcal infection
|
|
FR2884830A1
(fr)
|
2005-04-25 |
2006-10-27 |
Sanofi Pasteur Sa |
Procede de production de souches de staphylococcus aureus surproductrices
|
|
PL3006458T3
(pl)
*
|
2005-07-29 |
2018-05-30 |
The Government Of The United States Of America, As Represented By The Secretary Of Health And Human Services |
Zmutowane egzotoksyny Pseudomonas o zmniejszonej antygenowości
|
|
WO2007113222A2
(en)
*
|
2006-03-30 |
2007-10-11 |
Glaxosmithkline Biologicals S.A. |
Immunogenic composition
|
|
FR2899110A1
(fr)
*
|
2006-03-31 |
2007-10-05 |
Sanofi Pasteur Sa |
Polysaccharides capsulaires de type 5 et de type 8 des souches surproductrices de staphylococcus aureus
|
|
GB0700136D0
(en)
*
|
2007-01-04 |
2007-02-14 |
Glaxosmithkline Biolog Sa |
Process for manufacturing vaccines
|
|
US9181329B2
(en)
|
2007-08-31 |
2015-11-10 |
The University Of Chicago |
Methods and compositions related to immunizing against Staphylococcal lung diseases and conditions
|
|
JP5658564B2
(ja)
*
|
2007-08-31 |
2015-01-28 |
ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ |
ブドウ球菌肺疾患および状態に対する免疫に関連した方法および組成物
|
|
KR101573648B1
(ko)
|
2008-07-21 |
2015-12-01 |
더 브리검 앤드 우먼즈 하스피털, 인크. |
합성 베타-1,6 글루코사민 올리고당에 관한 방법 및 조성물
|
|
WO2010014304A1
(en)
*
|
2008-07-29 |
2010-02-04 |
University Of Chicago |
Compositions and methods related to staphylococcal bacterium proteins
|
|
HUE026855T2
(en)
|
2009-04-03 |
2016-07-28 |
Univ Chicago |
Compositions and methods related to protein a (spa) variants
|
|
WO2011041003A2
(en)
|
2009-06-22 |
2011-04-07 |
Wyeth Llc |
Compositions and methods for preparing staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions
|
|
SI2445522T1
(sl)
|
2009-06-22 |
2017-10-30 |
Wyeth Llc |
Imunogeni sestavki antigenov Staphylococcusa aureusa
|
|
GB0913681D0
(en)
|
2009-08-05 |
2009-09-16 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
|
GB0913680D0
(en)
|
2009-08-05 |
2009-09-16 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
|
MX373250B
(es)
|
2009-09-30 |
2020-05-04 |
Glaxosmithkline Biologicals S A Star |
Conjugación de polisacáridos capsulares de tipo 5 y de tipo 8 de staphylococcus aureus.
|
|
BR112012010223A2
(pt)
|
2009-10-30 |
2016-12-06 |
Novartis Ag |
purificação de staphylococcus aureus tipo 5 e tipo 8 sacarídeos capsulares
|
|
AU2010342872B2
(en)
*
|
2010-01-19 |
2014-09-25 |
Universitatsklinikum Freiburg |
Enterococcal cell wall components and antibacterial use thereof
|
|
SG186290A1
(en)
|
2010-07-02 |
2013-01-30 |
Univ Chicago |
Compositions and methods related to protein a (spa) variants
|
|
CN102565354A
(zh)
*
|
2010-12-13 |
2012-07-11 |
苏州艾杰生物科技有限公司 |
氨(氨离子)的测定方法与氨(氨离子)诊断/测定试剂盒
|
|
CN102539726A
(zh)
*
|
2010-12-13 |
2012-07-04 |
苏州艾杰生物科技有限公司 |
氨(氨离子)的测定方法与氨(氨离子)诊断/测定试剂盒
|
|
CN102539708A
(zh)
*
|
2010-12-13 |
2012-07-04 |
苏州艾杰生物科技有限公司 |
氨(氨离子)的测定方法与氨(氨离子)诊断/测定试剂盒
|
|
CN102539702A
(zh)
*
|
2010-12-13 |
2012-07-04 |
苏州艾杰生物科技有限公司 |
氨(氨离子)的测定方法与氨(氨离子)诊断/测定试剂盒
|
|
CN102565332A
(zh)
*
|
2010-12-13 |
2012-07-11 |
苏州艾杰生物科技有限公司 |
氨(氨离子)的测定方法与氨(氨离子)诊断/测定试剂盒
|
|
CN102565336A
(zh)
*
|
2010-12-13 |
2012-07-11 |
苏州艾杰生物科技有限公司 |
氨(氨离子)的测定方法与氨(氨离子)诊断/测定试剂盒
|
|
CN102539704A
(zh)
*
|
2010-12-13 |
2012-07-04 |
苏州艾杰生物科技有限公司 |
氨(氨离子)的测定方法与氨(氨离子)诊断/测定试剂盒
|
|
US8945588B2
(en)
|
2011-05-06 |
2015-02-03 |
The University Of Chicago |
Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
|
|
WO2014013375A1
(en)
|
2012-07-16 |
2014-01-23 |
Pfizer Inc. |
Saccharides and uses thereof
|
|
GB201310008D0
(en)
|
2013-06-05 |
2013-07-17 |
Glaxosmithkline Biolog Sa |
Immunogenic composition for use in therapy
|
|
WO2016091904A1
(en)
|
2014-12-10 |
2016-06-16 |
Glaxosmithkline Biologicals Sa |
Method of treatment
|
|
GB201721576D0
(en)
|
2017-12-21 |
2018-02-07 |
Glaxosmithkline Biologicals Sa |
Hla antigens and glycoconjugates thereof
|
|
GB201721582D0
(en)
|
2017-12-21 |
2018-02-07 |
Glaxosmithkline Biologicals Sa |
S aureus antigens and immunogenic compositions
|
|
US12397014B2
(en)
|
2019-02-05 |
2025-08-26 |
The Brigham And Women's Hospital, Inc. |
Polysaccharide compositions for use in treating filariasis
|
|
EP3777884A1
(en)
|
2019-08-15 |
2021-02-17 |
GlaxoSmithKline Biologicals S.A. |
Immunogenic composition
|
|
KR20220079534A
(ko)
*
|
2019-08-27 |
2022-06-13 |
알로펙스, 인크. |
항미생물 백신 조성물
|
|
WO2023133143A1
(en)
*
|
2022-01-05 |
2023-07-13 |
Bluewillow Biologics, Inc. |
Intranasal polysaccharide conjugate nanoemulsion vaccines and methods of using the same
|